patient's diabetes using a groundbreaking cell therapy. This pioneering treatment was developed by a team from Shanghai Changzheng Hospital, the Centre for Excellence in Molecular Cell Science under the Chinese Academy of Sciences, and Renji Hospital, and was detailed in the journal Cell Discovery on April 30.
According to a South China Morning Post report, the patient underwent the cell transplant in July 2021. Remarkably, within eleven weeks, he no longer required external insulin. Over the next year, he gradually reduced and ultimately stopped taking oral medication for blood sugar control. «Follow-up examinations showed that the patient’s pancreatic islet function was effectively restored,» said Yin, one of the lead researchers. The patient has now been insulin-free for 33 months.
This breakthrough marks a significant advancement in cell therapy for diabetes. Timothy Kieffer, a professor at the University of British Columbia, praised the study, saying, «I think this study represents an important advance in the field of cell therapy for diabetes.»
Diabetes is a chronic condition that affects the body's ability to convert food into energy, leading to severe complications if not managed properly. Traditional treatments involve insulin injections and constant monitoring, which can be burdensome for patients.
The new therapy involves programming the patient's peripheral blood mononuclear cells, transforming them into «seed cells» to recreate
Read more on economictimes.indiatimes.com